|Bid||5.32 x 1400|
|Ask||5.36 x 1000|
|Day's Range||5.16 - 5.38|
|52 Week Range||1.08 - 5.82|
|Beta (5Y Monthly)||1.67|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
If you own shares in Stereotaxis, Inc. (NYSEMKT:STXS) then it's worth thinking about how it contributes to the...
Hedge funds are known to underperform the bull markets but that's not because they are bad at investing. Truth be told, most hedge fund managers and other smaller players within this industry are very smart and skilled investors. Of course, they may also make wrong bets in some instances, but no one knows what the […]
A look at the shareholders of Stereotaxis, Inc. (NYSEMKT:STXS) can tell us which group is most powerful. Insiders...
DAFNA Capital Management was founded in 1999 by Dr. Nathan Fischel, who is the fund’s CEO. Dr. Fischel is Pediatric Hematologist-Oncologist with a long career in medicine. He graduated from Technion School of Medicine in Israel and completed his residency at the Children’s Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston. He continued his […]